Product NDC: | 0338-5197 |
Proprietary Name: | Famotidine |
Non Proprietary Name: | Famotidine |
Active Ingredient(s): | 20 mg/50mL & nbsp; Famotidine |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0338-5197 |
Labeler Name: | Baxter Healthcare Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075591 |
Marketing Category: | ANDA |
Start Marketing Date: | 20010510 |
Package NDC: | 0338-5197-41 |
Package Description: | 12 BAG in 1 CARTON (0338-5197-41) > 50 mL in 1 BAG |
NDC Code | 0338-5197-41 |
Proprietary Name | Famotidine |
Package Description | 12 BAG in 1 CARTON (0338-5197-41) > 50 mL in 1 BAG |
Product NDC | 0338-5197 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Famotidine |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20010510 |
Marketing Category Name | ANDA |
Labeler Name | Baxter Healthcare Corporation |
Substance Name | FAMOTIDINE |
Strength Number | 20 |
Strength Unit | mg/50mL |
Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |